Location History:
- Cranbury, NJ (US) (2004 - 2007)
- Princeton, NJ (US) (2010 - 2012)
Company Filing History:
Years Active: 2004-2012
Title: Innovations of Inventor Xin Huang
Introduction
Xin Huang is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the development of biomarkers and organic anion transport proteins. With a total of 4 patents to his name, his work has the potential to impact cancer treatment and drug delivery systems.
Latest Patents
One of Xin Huang's latest patents focuses on biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators. This patent outlines a method for predicting the likelihood that a mammal will respond therapeutically to cancer treatment involving an EGFR modulator. The method includes measuring the levels of specific biomarkers, such as epiregulin and amphiregulin, in a mammal before and after exposure to the modulator. An increase in these biomarker levels indicates a higher likelihood of therapeutic response.
Another significant patent involves the discovery of nucleic acid and amino acid sequences for novel organic anion transport proteins (OATPs). This invention encompasses the OATPs, vectors containing the cDNA sequences, host cells, and polypeptides related to OATPs. The applications of these proteins include targeting drugs to specific organs and modulating the concentration of endogenous substrates.
Career Highlights
Xin Huang is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the field of drug development. His work has been instrumental in advancing therapeutic strategies that leverage the body's biological mechanisms.
Collaborations
Xin has collaborated with notable colleagues, including Todd G Kirchgessner and Bonnie Hsiang, who contribute to the research and development efforts in their respective fields.
Conclusion
Xin Huang's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and drug delivery systems.